Track topics on Twitter Track topics that are important to you
KOL Perceptions of Ustekinumab Data Presented at ACR 2017
This KOL Insight briefing focuses on perceptions of Ustekinumab Data Presented at ACR 2017.
The briefing includes analysis of KOL opinion on the following topic areas
Perception of ustekinumab's Phase II efficacy data in SLE
Views on ustekinumab demonstrating significant efficacy at Week 24 in SLE
Ustekinumab's Phase II CLASI data in SLE
Ustekinumab's Phase II safety data in SLE
Impact of ustekinumab data in other indications on opinion of ustekinumab in SLE
Endpoints used in the Phase II ustekinumab trial in SLE
Anticipated future use of ustekinumab in SLE
Ideal additional endpoints or data for future ustekinumab trials in lupus
Most KOLs had a positive opinion of ustekinumab's efficacy in SLE and highlighted that it appears to have a better response rate vs. belimumab
KOLs were broadly impressed with ustekinumab's CLASI data, and expect it to encourage ustekinumab uptake in lupus skin manifestations
Most KOLs had a positive view of ustekinumab's safety, but concerns were raised regarding the small patient population in the Phase II trial.
The insight briefing is based on Sociable Pharma's analysis of primary research with our lupus key opinion leaders KOLs
In total, we conducted interviews with 14 KOLs: Seven Europebased seven USbased
Interviews performed in December 2017.
Reasons to buy
Combines Qualitative semiquantitative insight from key opinion leaders on "Ustekinumab Data Presented at ACR 2017"
Includes insight recommendations from our diseasespecific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data emerging trends on management of Lupus
Provides costeffective support for your advisory boards, with topics acting as a catalyst for further expert discussion.NEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...